ETA2022 Poster Presentations Case Reports (9 abstracts)
Carpal Tunnel Syndrome in Subclinical Hypothyreosis
Shushanik Kostandyan 1 , Armine Khroyan 2 , Elena Aghajanova 3 , Artashes Tadevosyan 4 & Lilit Kambulyan 5
1Yerevan State Medical University, Muratsan University Hospital, Yerevan, Armenia; 2Yerevan State Medical University, Koryun 2, Endocrinology, Yerevan, Armenia; 3Yerevan State Medical University, Muratsan University Hospital, Endocrinology, Yerevan, Armenia; 4Yerevan State Medical University, Yerevan State Medical University, Armenia; 5Yerevan State Medical University, Yerevan State Medical University, Endocrinology, Yerevan, Armenia
Introduction: Is treatment with Levothyroxine indicated for subclinical hypothyreosis concomitant with Carpal Tunnel Syndrome?
Case Report: The patient, a 35-year-old woman, applied to “Muratsan” Polyclinic in Armenia with complaints of weakness, fatigue, dry skin, pain in hands, swelling, numbness, all these intensified at night. The above mentioned complaints appeared approx a year ago.
The following findings have been determined:
| Test | Result | Normal range |
| TSH | 5.6 Uiu/ml | 0.27-4.2 uIU/ml |
| FT4 | 1.2 ng/dl | 0.93-1.7 ng/dl |
| Anti-TPO | 16 IU/ml | <34 IU/ml |
| CRP | Normal range | |
| RF | Normal range | |
| ASLO | Normal range | |
| CBC | Normal range | |
| Thyroid gland ultrasound | Diffuse Goiter | |
| Electroneuromyography | No conductance disturbance; however there is pressure on the median nerve. | |
| DS: Diffuse Goiter, Subclinical Hypothyreosis. Carpal Tunnel Syndrome. No medication was prescribed by neurologists as there was no conductance disturbance. Levothyroxine 50 mg was prescribed by endocrinologist once daily. After 3 months a follow-up was conducted and the patient’s condition was assessed. As a result of the prescribed treatment, all the clinical symptoms related to the Carpal Tunnel disappeared. | ||
Conclusions: In case of Subclinical Hypothyreosis and Carpal Tunnel Syndrome it is recommended to prescribe Levothyroxine for 3 months, thereafter the patient’s condition should be assessed. If the clinical symptoms subside or disappear on the background of the treatment, continue treatment with Levothyroxine, if not then stop the treatment.
Article tools
My recent searches
My recently viewed abstracts
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more